PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a finished-dose generic company from Egypt, Gulf and MENA

Selling into Europe as a finished-dose generic company from Egypt, Gulf and MENA

Your team files European dossiers that clear validation the first time.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Egypt, Gulf and MENA, Finished-dose generic companywho it is written for

Why this training matters

Your first European application reaches validation and comes back: a Module 1 document is missing. Your regulatory team reopens a dossier they called finished, and the launch date moves. The board asks why Europe was ever on the plan.

What changes after this course

Your team builds the dossier, the quality system and the safety set-up to European rules from the start. They answer an inspector's question from the file, not from memory. You hold a certificate for each learner and a training record for each person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs lead picks the route in one meeting: Centralized, Decentralized or Mutual Recognition, with the reason written down. Your submission staff write Module 3 under 3.2.S and 3.2.P with the stability data laid out for the assessor, and Module 1 goes in complete under Directive 2001/83/EC, so validation stops being a surprise.

Plant managers walk the site against EudraLex Volume 4 and update the Site Master File before the inspection letter arrives. Your pharmacovigilance officer works with a Qualified Person for Pharmacovigilance based in the European Economic Area, and the Pharmacovigilance System Master File and the reporting clock are ready before the first sale.

Commercial directors price with the country's tender, rebate and reference-pricing rules in front of them, and they sign distribution contracts that name who holds the marketing authorization. Packaging supervisors apply the unique identifier and anti-tampering device required by the Falsified Medicines Directive, and logistics partners are checked against the Good Distribution Practice guidelines.

After approval, a process change stops being an emergency. Your staff decide whether it is a Type IA, Type IB or Type II variation, file it, and put the renewal application in the calendar nine months before the five-year mark. When an authority attaches a new commitment, someone already owns it.

Who needs this training

  • Regulatory Affairs Manager

    The week a new generic is ready to file, they choose between the Centralized, Decentralized and Mutual Recognition routes and defend the choice to management with the Article 10 basis in hand.

  • Head of Quality Assurance

    When the inspection notice arrives, they open a Site Master File already matched to EudraLex Volume 4, instead of rewriting it in the weeks before inspectors walk in.

  • Business Development Manager

    Before signing a distribution deal in a new member state, they check tender, rebate and reference-pricing rules and the contract clauses on who holds the marketing authorization.

  • Pharmacovigilance Officer

    On the day a serious adverse reaction report is received, they know the deadline, the route into EudraVigilance and what the Qualified Person for Pharmacovigilance must sign off.

  • Export and International Sales Manager

    When a pallet leaves for Europe, they know the Good Distribution Practice checks, the pack features the Falsified Medicines Directive requires and what the importer must certify.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Finished-dose generic company

Countries: Egypt, Gulf and MENA

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the Centralized, Decentralized and Mutual Recognition Procedures for a named generic product and write down the reason.
  2. Assemble Module 3 sections 3.2.S and 3.2.P with a stability summary that supports the shelf life you propose.
  3. Check a Module 1 package against a validation list and spot the missing country-specific document before submission.
  4. Map your quality system to EudraLex Volume 4 and list the documents an inspector asks for first.
  5. Outline the Pharmacovigilance System Master File and set the reporting timeline for serious adverse reactions.
  6. Audit a distributor against the Good Distribution Practice guidelines and mark where Falsified Medicines Directive safety features are missing from packs.
  7. Classify a post-approval change as Type IA, Type IB or Type II and prepare the variation request.

What the company gets

  • Your dossiers are checked against validation requirements before you submit, so fewer come back for missing Module 1 documents or gaps in Module 3.
  • Your sites hold a Site Master File and quality records matched to EudraLex Volume 4 before an inspector asks for them.
  • Your commercial team picks launch countries by tender rules and reference pricing, and signs partner contracts that keep the marketing authorization where it belongs.
  • Your safety system has a named Qualified Person for Pharmacovigilance, a master file and a reporting clock that the person can sign off.
  • Each learner leaves with a certificate and a training record, so an auditor sees who was trained, on what, and when.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Size up the European generic market and pick the countries to launch in

    • Why your product list decides which of the 27 member states you enter first.
    • How to read a country's generic market by its tenders, substitution rules and reference prices.
    • What to check about competitors and market size so your first launch country is one you can win.
  2. 2Apply Directive 2001/83/EC and the EU rules that govern generic approval

    • How Article 10 of Directive 2001/83/EC lets your generic skip the originator's full trial package.
    • Why the marketing authorization holder must sit inside the European Economic Area.
    • Who decides what: the European Medicines Agency, the Commission or the national agency.
  3. 3Build a quality system that meets EudraLex Volume 4 at inspection

    • How to line up your Pharmaceutical Quality System with EudraLex Volume 4, Part I, chapter by chapter.
    • The site documents an inspector asks for first, starting with the Site Master File.
    • Why some audit findings end in a non-compliance statement, and what closes them first.
  4. 4Draft a European market entry strategy your board can fund and follow

    • How to rank countries by effort and return, so your first launch is the easy one.
    • Which route to market fits a company with no European office: own affiliate, licensee or distributor.
    • What to cost out before the board signs, from dossier fees to stock held in Europe.
  5. 5Select the Marketing Authorization Application type that fits your product

    • When the Centralized Procedure suits your generic and when it does not.
    • How the Decentralized Procedure puts one dossier in front of several states at once.
    • What to do when you hold one national approval and want the Mutual Recognition Procedure for the rest.
  6. 6Write Common Technical Document Module 3 that survives quality assessment

    • What belongs in 3.2.S for the active substance and 3.2.P for the finished product.
    • How to present stability data so the assessor accepts the shelf life you ask for.
    • The questions assessors ask on specifications and validation, answered in the dossier before they ask.
  7. 7Prepare Common Technical Document Modules 1 and 2 without validation queries

    • How to build Module 1: application form, product information and each country's extra documents.
    • What the Quality Overall Summary, Nonclinical Overview and Clinical Overview must each say in Module 2.
    • Why a missing Module 1 item stops validation and how a pre-submission check catches it.
  8. 8Set up a European pharmacovigilance system with a named responsible person

    • Why your Qualified Person for Pharmacovigilance must be based in the European Economic Area.
    • What goes into the Pharmacovigilance System Master File and who keeps it current.
    • What to do when a serious adverse reaction report is due and the clock has already started.
  9. 9Set prices and win reimbursement in each member state you enter

    • How reference pricing in one country pulls down your price in the next.
    • Why a generic's price depends on tenders, rebates and substitution rules, country by country.
    • What to put in a reimbursement file so the payer sees a saving, not a cost.
  10. 10Direct a European supply chain that meets Good Distribution Practice

    • How to check your logistics partners against the Good Distribution Practice guidelines of 2013.
    • What the Falsified Medicines Directive needs on a pack: the safety features, and which products carry them.
    • When parallel trade eats your margin and what pack and price choices limit it.
  11. 11Secure European partners and contracts that protect your product and margin

    • How to vet a licensee or distributor before you share your dossier.
    • The contract clauses that decide who holds the marketing authorization, and who can take it away.
    • Why a distributor's recall and complaint handling belongs in the contract, not the handshake.
  12. 12Direct variations, renewals and post-approval duties after approval

    • How to sort a manufacturing change into Type IA, Type IB or Type II before you file.
    • When to file your renewal application: at least nine months before the five-year mark.
    • What to do when an authority attaches a new post-approval commitment to your product.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Egypt, Gulf and MENA, Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team